ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

http://www.kuka.com/cyberknife

Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference https://investors.accuray.com/news-releases/news-release-details/accuray-participate-btig-medtech-digital-health-life-science-0 ...announced today its participation in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023. ...

Jetzt darf das Pferd mal rennen

https://www.prnewswire.com/news-releases/robert-c-kill-joins-accuray-board-of-directors-301735852.html

Accuray Reports Fiscal 2023 Second Quarter Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2023-second-quarter-financial-results-301735652.html Delivered strong Q2 performance amidst challenging macroenvironment; Reiterate fiscal year guidance    

http://ow.ly/GOKA50MAWOq

European Radiosurgery Center Munich Invests in Second Accuray CyberKnife® System to Support the Demand for High-Precision Radiosurgery Treatments https://www.prnewswire.com/news-releases/european-radiosurgery-center-munich-invests-in-second-accuray-cyberknife-system-to-support-the-demand-for-high-precision-radiosurgery-treatments-301731318.html • Center believes the CyberKnife System is the #1 tool for delivery of advanced radiosurgery treatments • Selected the latest generation CyberKnife S7™ System to increase the number of indications they can treat throughout the body, and the patients they can help

https://m.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/

Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits (form 8-K) https://www.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/ ...informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approximately 4.5 percent of its global workforce. The Company expects to substantially complete the cost saving initiative in the second quarter of fiscal 2023. The Company estimates the total cost of this initiative to be approximately $2.0 million, which is expected to be recorded in the second quarter of fiscal 2023.

https://finance.yahoo.com/news/accuray-receives-imv-award-best-131000336.html

https://investors.accuray.com/news-releases/news-release-details/oscar-lambret-center-france-installs-second-accuray-radixactr

https://www.nasdaq.com/articles/accuray-incorporated-q1-loss-increases-misses-estimates Accuray Incorporated Q1 Loss increases, misses estimates

Accuray Reports Fiscal 2023 First Quarter Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2023-first-quarter-financial-results-301666588.html Strong customer demand. Navigating FX and Supply Chain Challenges. Company reiterates full year guidance. 

Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration https://www.prnewswire.com/news-releases/accuray-announces-tomo-c-registration-submission-to-chinas-national-medical-products-administration-301664095.html

New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain https://www.prnewswire.com/news-releases/new-reimbursement-approved-by-the-japanese-ministry-of-health-labor-and-welfare-for-the-accuray-cyberknife-system-to-treat-trigeminal-neuralgia-a-condition-often-causing-severe-facial-pain-301659442.html

https://investors.accuray.com/news-releases/news-release-details/ge-healthcare-and-accuray-collaborate-expand-access-advance